Skip to content
Coming soon
  • Agriculture Tech
  • AI Agents & Models
  • Autonomy
  • Avatars & Digital Humans
  • Biotech / Synthetic Biology
  • Blockchain / Crypto
  • Brain-Computer Interfaces
  • Climate Tech
  • Cloud & Edge Computing
  • Commerce
  • Cybersecurity
  • Data Infrastructure
  • Defense
  • Digital Identity
  • Education Tech
  • Energy
  • Fashion & Textiles
  • Food Tech
  • Healthcare Systems
  • Longevity & Human Enhancement
  • Manufacturing
  • Materials Science
  • Mobility
  • Quantum Computing
  • Semiconductors
  • Smart Homes
  • Space Tech
  • Spatial Computing
  • Voice & Conversational Interfaces
  • Wearables

Ro

Ro operates a vertically integrated telehealth platform spanning men's and women's health, weight management (Body Program), and at-home diagnostics with in-house pharmacy fulfillment. Valued at $6.6B (2022). Raised $1B+. Launched GLP-1 Body Program, partnered with Eli Lilly on Zepbound. Built in-house pharmacy network. D2C plus B2B model.
Ro's vertical integration — owning the telehealth interface, diagnostics, pharmacy, and provider network — makes it the most ambitious full-stack consumer health company; its Body Program with GLP-1s is a major growth driver.
ro.co Virtual Care DeliveryUnited States flagUnited Statesprivate

At a glance

Total raised
$1.0B
last round growth
Headcount
501-1k
approximate · public range
Headquarters
New York
United States flagUnited States
Founded
2017
9 years active
Status
Private
Virtual Care Delivery
Latest valuation
$7B
Growth · 2022
For subscribers

Subscribe to see the full profile

Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.

Founding
50% off
$5
/month
 
94 of 100 spots left
Full
$10
/month
 
Available once all 100 Founding Member spots are claimed.
Get full access

Already subscribed? Sign in →